These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nigeria's unending war with Lassa fever. Adepoju P Lancet; 2019 Feb; 393(10172):627-628. PubMed ID: 30833112 [No Abstract] [Full Text] [Related]
4. Global lessons from Nigeria's ebolavirus control strategy. Elemuwa C; Kutalek R; Ali M; Mworozi E; Kochhar S; Rath B; Expert Rev Vaccines; 2015; 14(11):1397-400. PubMed ID: 26190046 [TBL] [Abstract][Full Text] [Related]
5. Lessons learnt from the management of a case of Lassa fever and follow-up of nosocomial primary contacts in Nigeria during Ebola virus disease outbreak in West Africa. Iroezindu MO; Unigwe US; Okwara CC; Ozoh GA; Ndu AC; Ohanu ME; Nwoko UO; Okoroafor UW; Ejimudo E; Tobin EA; Asogun DA Trop Med Int Health; 2015 Nov; 20(11):1424-1430. PubMed ID: 26171669 [TBL] [Abstract][Full Text] [Related]
6. DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs. Cashman KA; Wilkinson ER; Wollen SE; Shamblin JD; Zelko JM; Bearss JJ; Zeng X; Broderick KE; Schmaljohn CS Hum Vaccin Immunother; 2017 Dec; 13(12):3010-3019. PubMed ID: 29135337 [TBL] [Abstract][Full Text] [Related]
8. Transmission dynamics and control of Ebola virus disease outbreak in Nigeria, July to September 2014. Fasina FO; Shittu A; Lazarus D; Tomori O; Simonsen L; Viboud C; Chowell G Euro Surveill; 2014 Oct; 19(40):20920. PubMed ID: 25323076 [TBL] [Abstract][Full Text] [Related]
9. Delayed inflammatory and cell death responses are associated with reduced pathogenicity in Lujo virus-infected cynomolgus macaques. Rasmussen AL; Tchitchek N; Safronetz D; Carter VS; Williams CM; Haddock E; Korth MJ; Feldmann H; Katze MG J Virol; 2015 Mar; 89(5):2543-52. PubMed ID: 25520505 [TBL] [Abstract][Full Text] [Related]
10. Immunobiology of Ebola and Lassa virus infections. Prescott JB; Marzi A; Safronetz D; Robertson SJ; Feldmann H; Best SM Nat Rev Immunol; 2017 Mar; 17(3):195-207. PubMed ID: 28111475 [TBL] [Abstract][Full Text] [Related]
11. Pre-clinical development of a vaccine against Lassa fever. Banadyga L; Stein DR; Qiu X; Safronetz D Can Commun Dis Rep; 2018 Jun; 44(6):139-147. PubMed ID: 31015807 [TBL] [Abstract][Full Text] [Related]
12. Re-emerging Lassa fever outbreaks in Nigeria: Re-enforcing "One Health" community surveillance and emergency response practice. Tambo E; Adetunde OT; Olalubi OA Infect Dis Poverty; 2018 Apr; 7(1):37. PubMed ID: 29703243 [TBL] [Abstract][Full Text] [Related]
13. A medical records and data capture and management system for Lassa fever in Sierra Leone: Approach, implementation, and challenges. Shaffer JG; Schieffelin JS; Gbakie M; Alhasan F; Roberts NB; Goba A; Randazzo J; Momoh M; Moon TD; Kanneh L; Levy DC; Podgorski RM; Hartnett JN; Boisen ML; Branco LM; Samuels R; Grant DS; Garry RF; PLoS One; 2019; 14(3):e0214284. PubMed ID: 30921383 [TBL] [Abstract][Full Text] [Related]
14. Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses. Pushko P; Geisbert J; Parker M; Jahrling P; Smith J J Virol; 2001 Dec; 75(23):11677-85. PubMed ID: 11689649 [TBL] [Abstract][Full Text] [Related]
15. Reorganizing Nigeria's Vaccine Supply Chain Reduces Need For Additional Storage Facilities, But More Storage Is Required. Shittu E; Harnly M; Whitaker S; Miller R Health Aff (Millwood); 2016 Feb; 35(2):293-300. PubMed ID: 26858383 [TBL] [Abstract][Full Text] [Related]
18. Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January-March 2012). Ajayi NA; Nwigwe CG; Azuogu BN; Onyire BN; Nwonwu EU; Ogbonnaya LU; Onwe FI; Ekaete T; Günther S; Ukwaja KN Int J Infect Dis; 2013 Nov; 17(11):e1011-6. PubMed ID: 23871405 [TBL] [Abstract][Full Text] [Related]
19. The etiology of Ebola virus disease-like illnesses in Ebola virusnegative patients from Sierra Leone. Li WG; Chen WW; Li L; Ji D; Ji YJ; Li C; Gao XD; Wang LF; Zhao M; Duan XZ; Duan HJ Oncotarget; 2016 May; 7(19):27910-5. PubMed ID: 27058894 [TBL] [Abstract][Full Text] [Related]
20. Lethal Infection of Lassa Virus Isolated from a Human Clinical Sample in Outbred Guinea Pigs without Adaptation. Maruyama J; Manning JT; Mateer EJ; Sattler R; Bukreyeva N; Huang C; Paessler S mSphere; 2019 Sep; 4(5):. PubMed ID: 31554720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]